Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report

被引:0
|
作者
Yosuke Suehiro
Takuro Uchida
Masataka Tsuge
Eisuke Murakami
Daiki Miki
Tomokazu Kawaoka
Michio Imamura
Hiroshi Aikata
Koji Arihiro
Shiro Oka
机构
[1] Hiroshima University,Department of Gastroenterology, Graduate School of Biomedical and Health Sciences
[2] Hiroshima University,Natural Science Center for Basic Research and Development
[3] Hiroshima University Hospital,Department of Pathology
来源
关键词
Acute liver injury; Non-alcoholic steatohepatitis; Chloroform exposure;
D O I
暂无
中图分类号
学科分类号
摘要
We report a rare case of acute liver injury by daily exposure to small amounts of chloroform in non-alcoholic fatty liver disease (NAFLD) patient. The patient had been followed up in our hospital every 3 months. Although his alanine aminotransferase (ALT) levels were steady around 30 ~ 60 U/L until August 2014, ALT level was spontaneously increased to more than 1,000 U/L at the follow-up point in late August 2014. As he was diagnosed as acute liver injury by chloroform exposure, we withdrew him from the exposure of chloroform and treated him with 600 mg/day of ursodeoxycholic acid. Afterwards, his ALT level rapidly improved and normalized within 1 month. To verify the influences of chloroform exposure, we measured plasma chloroform levels by gas chromatography. Although plasma chloroform concentration was 7.1 ng/ml (normal range: < 0.2 ng/ml) at the time of liver injury, the concentration had decreased to 0.7 ng/ml by 1 month later. Despite the fact that he had put on a face mask to protect from aspiration of chloroform, liver injury still occurred in the present case. Chloroform has a high solubility for lipids and accumulation of lipids in the liver might become a risk factor for liver injury by chloroform.
引用
收藏
页码:250 / 253
页数:3
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease and liver secretome
    Muhammad Sohaib Khan
    Choongho Lee
    Sang Geon Kim
    Archives of Pharmacal Research, 2022, 45 : 938 - 963
  • [32] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [34] Effective Management of Non-alcoholic Fatty liver disease with Siravedha - A Case Report
    Sawarkar, Gaurav
    Sawarkar, Punam
    INTERNATIONAL JOURNAL OF AYURVEDIC MEDICINE, 2022, 13 (01) : 219 - 222
  • [35] Non-alcoholic Fatty Liver Disease in a Jamaican Patient Population
    King-Robinson, K.
    Lee, M. G.
    Whittle, D.
    Mills, M.
    Hanchard, B.
    Shah, S.
    WEST INDIAN MEDICAL JOURNAL, 2016, 65 (03): : 557 - 560
  • [36] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [37] Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
    Wu, Dongqing
    Zhu, Huaqing
    Wang, Hua
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [38] Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Yamamura, Sakura
    Nakano, Dan
    Hashida, Ryuki
    Tsutsumi, Tsubasa
    Kawaguchi, Takumi
    Okada, Michiaki
    Isoda, Hiroshi
    Takahashi, Hirokazu
    Matsuse, Hiroo
    Eguchi, Yuichiro
    Sumida, Yoshio
    Nakajima, Atsushi
    Gerber, Lynn
    Younossi, Zobair M.
    Torimura, Takuji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (03) : 629 - 636
  • [39] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [40] Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
    Chantarojanasiri, Tanyaporn
    DRUGS IN CONTEXT, 2023, 12